Clínica Baviera, S.A. (CBAV.MC)
EUR 31.4
(-1.26%)
EUR 31.4
(-1.26%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 86.36 Million EUR | 5.67% |
| 2022 | 81.73 Million EUR | 4.23% |
| 2021 | 78.41 Million EUR | 3.15% |
| 2020 | 76.01 Million EUR | 7.43% |
| 2019 | 70.76 Million EUR | 161.43% |
| 2018 | 27.06 Million EUR | -7.03% |
| 2017 | 29.11 Million EUR | 3.27% |
| 2016 | 28.19 Million EUR | 12.46% |
| 2015 | 25.06 Million EUR | -13.07% |
| 2014 | 28.83 Million EUR | 25.74% |
| 2013 | 22.93 Million EUR | -25.57% |
| 2012 | 30.81 Million EUR | -9.46% |
| 2011 | 34.02 Million EUR | -1.19% |
| 2010 | 34.43 Million EUR | -9.1% |
| 2009 | 37.88 Million EUR | -15.98% |
| 2008 | 45.09 Million EUR | 77.75% |
| 2007 | 25.37 Million EUR | 6.15% |
| 2006 | 23.9 Million EUR | 51.51% |
| 2005 | 15.77 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 89.26 Million EUR | 3.36% |
| 2024 Q2 | 122.34 Million EUR | 37.05% |
| 2023 Q4 | 86.36 Million EUR | -7.57% |
| 2023 Q2 | 93.94 Million EUR | -0.79% |
| 2023 Q1 | 94.69 Million EUR | 132.68% |
| 2023 Q3 | 93.44 Million EUR | -0.54% |
| 2023 FY | 86.36 Million EUR | 5.67% |
| 2022 Q2 | 76.45 Million EUR | 0.97% |
| 2022 Q1 | 75.72 Million EUR | -3.44% |
| 2022 FY | 81.73 Million EUR | 4.23% |
| 2022 Q4 | 40.69 Million EUR | -44.17% |
| 2022 Q3 | 72.89 Million EUR | -4.65% |
| 2021 Q1 | 76.84 Million EUR | 1.09% |
| 2021 Q3 | 73.39 Million EUR | -3.05% |
| 2021 Q4 | 78.41 Million EUR | 6.83% |
| 2021 Q2 | 75.7 Million EUR | -1.48% |
| 2021 FY | 78.41 Million EUR | 3.15% |
| 2020 Q1 | 76.87 Million EUR | 8.65% |
| 2020 Q2 | 75.34 Million EUR | -2.0% |
| 2020 Q3 | 75.1 Million EUR | -0.32% |
| 2020 Q4 | 76.01 Million EUR | 1.22% |
| 2020 FY | 76.01 Million EUR | 7.43% |
| 2019 Q2 | 70.24 Million EUR | 10.38% |
| 2019 FY | 70.76 Million EUR | 161.43% |
| 2019 Q3 | 70.76 Million EUR | 0.74% |
| 2019 Q4 | 70.76 Million EUR | -0.01% |
| 2019 Q1 | 63.64 Million EUR | 135.14% |
| 2018 Q2 | 30.22 Million EUR | 0.0% |
| 2018 Q4 | 27.06 Million EUR | -8.23% |
| 2018 FY | 27.06 Million EUR | -7.03% |
| 2018 Q3 | 29.49 Million EUR | -2.43% |
| 2017 Q4 | 29.11 Million EUR | 0.0% |
| 2017 FY | 29.11 Million EUR | 3.27% |
| 2017 Q2 | 29.24 Million EUR | 6.34% |
| 2017 Q1 | 27.5 Million EUR | -2.44% |
| 2016 Q4 | 28.19 Million EUR | 0.0% |
| 2016 Q2 | 25.74 Million EUR | 0.0% |
| 2016 FY | 28.19 Million EUR | 12.46% |
| 2015 FY | 25.06 Million EUR | -13.07% |
| 2015 Q2 | 27.38 Million EUR | 0.0% |
| 2015 Q4 | 25.06 Million EUR | 0.0% |
| 2014 Q2 | 26.96 Million EUR | 0.0% |
| 2014 FY | 28.83 Million EUR | 25.74% |
| 2014 Q4 | 28.83 Million EUR | 0.0% |
| 2013 Q4 | 22.93 Million EUR | 0.0% |
| 2013 Q2 | 27 Million EUR | 0.0% |
| 2013 FY | 22.93 Million EUR | -25.57% |
| 2012 FY | 30.81 Million EUR | -9.46% |
| 2012 Q2 | 33.77 Million EUR | 0.0% |
| 2012 Q4 | 30.81 Million EUR | 0.0% |
| 2011 FY | 34.02 Million EUR | -1.19% |
| 2011 Q2 | 34.41 Million EUR | 0.0% |
| 2011 Q4 | 34.02 Million EUR | 0.0% |
| 2010 Q2 | 36.88 Million EUR | 0.0% |
| 2010 FY | 34.43 Million EUR | -9.1% |
| 2010 Q4 | 34.43 Million EUR | 0.0% |
| 2009 FY | 37.88 Million EUR | -15.98% |
| 2009 Q4 | 37.88 Million EUR | 0.0% |
| 2008 FY | 45.09 Million EUR | 77.75% |
| 2007 FY | 25.37 Million EUR | 6.15% |
| 2006 FY | 23.9 Million EUR | 51.51% |
| 2005 FY | 15.77 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pangaea Oncology, S.A. | 10.02 Million EUR | -761.502% |